Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis.

Hammond, E H; Wittwer, C T; Greenwood, J; Knape, W A; Yowell, R L; Menlove, R L; Craven, C; Renlund, D G; Bristow, M R; DeWitt, C W

Hammond, E H; Wittwer, C T; Greenwood, J; Knape, W A; Yowell, R L; Menlove, R L; Craven, C; Renlund, D G; Bristow, M R; DeWitt, C W.

Affiliation

Hammond EH; Utah Transplantation Affiliated Hospitals (UTAH) Cardiac Transplant Program, Salt Lake City.

Transplantation ; 50(5): 776-82, 1990 Nov.

Article in En | MEDLINE | ID: mdl-2122559

Subject(s)

Antibodies, Monoclonal/therapeutic use; Graft Rejection/immunology; Heart Transplantation; Antibodies, Anti-Idiotypic/analysis; Antibodies, Monoclonal/blood; Antibodies, Monoclonal/immunology; Antigen-Antibody Complex/analysis; Graft Occlusion, Vascular; Heart Transplantation/mortality; Humans; Muromonab-CD3

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Heart Transplantation / Graft Rejection / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Humans Language: En Journal: Transplantation Year: 1990 Type: Article

Search on Google

XML

PubMed Links